Jazz Pharmaceuticals Plc (JAZZ) Return on Investment ROI from the second quarter of 2026 to second quarter of 2025 and for the year 2026, average high and low, overall ranking from Jun 30 2026 to Jun 30 2025 - CSIMarket
CSIMarket Company Name, Ticker, Competitors, else..
 


• ROA Quarterly
• ROI Quarterly
• ROE Quarterly
Jazz Pharmaceuticals Plc  (NASDAQ: JAZZ)


Jazz Pharmaceuticals Plc's ROI from its second quarter of 2026 to the second quarter of 2025 and 5 Year Period

Return on Investment, Quarterly Results, Trends, Rankings, Statistics

What is Jazz Pharmaceuticals Plc's ROI in the second quarter of 2026?
Jazz Pharmaceuticals Plc achieved a return on average invested assets (ROI) of 10.77 % in its second quarter of 2026, this is above JAZZ's average return on investment of 8.42%.
Jazz Pharmaceuticals Plcs investments during the 12 months ending in the second quarter of 2026 are valued at $8 billion

Despite the deterioration in its net income, company has improved ROI compared to the first quarter of 2026.

Within the Healthcare sector 103 other companies had a higher return on investment. While return on investment, the total ranking has deteriorated compared to the first quarter of 2026 from 1599 to 2473.

Definition and Formula of Return on Investment


Download as CSV
Commercial Data Licensing & OEM
Annual commercial subscriptions for corporate use, internal BI systems, management reporting, AI integration, and client-facing platforms
API & Data Feeds
Programmatic access to normalized fundamentals & ratios.

Return On Investment (Jun 30 2026)
II. Quarter		 (Mar 31 2026)
I. Quarter		 (Dec 31 2025)
IV. Quarter		 (Sep 30 2025)
III. Quarter		 (Jun 30 2025)
II. Quarter
Y / Y Investment Change TTM -7.98 % -12.79 % -9.44 % -2.03 % 8.16 %
Y / Y Net Income Change TTM - -93.88 % - - -
Investment (TTM) in Millions 9,153 8,857 8,647 8,291 8,042
Return On Investment (TTM) 10.77 % 0.35 % -4.13 % -4.09 % -4.26 %
JAZZ's Overall Ranking # 2473 # 1599 # 2196 # 2645 # 2522
Seq. Investment Change TTM 3.28 % -1.9 % -4.23 % -5.16 % -2.12 %
Seq. Net Income Change TTM 3089.78 % - - - -
Net Income (TTM) in Millions 941 29 -356 -368 -405

JAZZ Company Profile >> Back to JAZZ Roi Comparisons >> See Annual JAZZ Return On Investment



Return On Investment JAZZ's Ranking
Within: No.
Industry # 41
Sector # 104
Overall # 2473

Return On Investment Statistics
High Average Low
85.99 %
8.42 %
-4.1 %
(Dec 31 2011)   (Mar 31 2022)







Financial Statements
Jazz Pharmaceuticals Plc's II. Quarter Investments $ 9,153 Millions JAZZ's Balance sheet
Jazz Pharmaceuticals Plc's II. Quarter Income $ 193 Millions Quarterly JAZZ's Income Statement
JAZZ's Income by Division See JAZZ's Income by Division


JAZZ Annual Return On Investment (Dec 31 2025)
2025		 (Dec 31 2024)
2024		 (Dec 31 2023)
2023		 (Dec 31 2022)
2022		 (Dec 31 2021)
2021
Total Investments in Millions 8,647 10,171 8,845 8,779 11,489
Y / Y Investment Growth -14.99 % 15 % 0.75 % -23.59 % 95.33 %
Net Income in Millions -356 560 415 -224 -330
Y / Y Net Income Growth - 35.02 % - - -
Annual Return On Investment -4.12 % 5.51 % 4.69 % -2.55 % -2.87 %


Annual Roi Comment


Definition and Formula of Return on Investment

Other ROI Ratios
Major Pharmaceutical Preparations Industry Roi Trends and Statistics
Healthcare Sector Return On Investment Statistics
Roi Trends for overall market
JAZZ's Roi Ratio versus Major Pharmaceutical Preparations Industry, Healthcare Sector and total Market
Highest Ranking Return On Investment
Lowest Ranking Return On Investment
Subscribers only: Roi for JAZZ's Competitors
Subscribers only: Roi for Jazz Pharmaceuticals Plc's Suppliers
Subscribers only: Return On Investment for JAZZ's Customers

Other Ratios
JAZZ's Roa JAZZ's Inventory Turnover Ratio JAZZ's Growth Rates JAZZ's Dividend Statistics
JAZZ's Profitability Ratios JAZZ's Asset Turnover Ratio JAZZ's Dividend Growth
JAZZ's Roe JAZZ's Valuation Ratios JAZZ's Financial Strength Ratios JAZZ's Dividend Payout Ratio



Companies with similar Return On Investment at Jun 30 2026, within Healthcare Sector ROI
Caredx Inc   29.42 %
Adma Biologics Inc   28.94 %
Protalix Biotherapeutics inc   25.72 %
Pro dex Inc   24.29 %
Innoviva Inc   23.33 %
Electromed Inc   23.18 %
Zevra Therapeutics Inc   22.90 %
Iradimed Corporation  22.57 %
Alnylam Pharmaceuticals Inc   22.10 %
Eton Pharmaceuticals Inc   21.31 %
Dexcom Inc   20.98 %
Healthcare Services Group Inc   20.93 %
Arcutis Biotherapeutics Inc   20.77 %
Chemed Corporation  20.13 %
Resmed Inc   20.01 %
Halozyme Therapeutics Inc   19.99 %
Vertex Pharmaceuticals Inc  19.97 %
Agilent Technologies inc   19.84 %
Illumina Inc   19.61 %
Puma Biotechnology Inc   19.60 %
United Therapeutics Corporation  19.53 %
Zoetis Inc   19.44 %
Krystal Biotech Inc   19.16 %
Carlisle Companies Incorporated  18.88 %
Neurocrine Biosciences Inc   17.51 %
Intuitive Surgical Inc   17.11 %
Theravance Biopharma inc   17.10 %
Standard Biotools Inc   16.38 %
Inspire Medical Systems inc   16.34 %
Aveanna Healthcare Holdings Inc   16.32 %

Date modified: 2026-09-12T18:36:12+00:00



Help

About us

Products

Data downloads

API

CSIMarket Company, Sector, Industry, Market Analysis, Stock Quotes, Earnings, Economy, News and Research.

Intraday data delayed per exchange requirements. All quotes are in local exchange time. Intraday data delayed 15 minutes for Nasdaq, and other exchanges. Fundamental and financial data for Stocks, Sector, Industry, and Economic Indicators provided by CSIMarket.com

Disclaimer: Information provided by CSIMarket.com is for informational purposes only and does not constitute investment advice, recommendation, or solicitation to buy or sell any security.

© 2026 CSIMarket.com — Proprietary financial dataset. All rights reserved. Redistribution or automated extraction prohibited.